Successful Treatment of Refractory Erythroderma with Abrocitinib: A Case Report
This case indicates that abrocitinib may be a promising therapeutic option for patients with erythroderma resistant to existing treatments. Further research with larger patient cohorts is necessary to establish its efficacy and safety in this context.
Authors
- Chen Li
- Jingjie Yu
- Yuping Zhang
- Chuanjian Lu
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Case Reports in Dermatology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1159/000550416
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China